Investing Profile

Chris Garabedian

InvestorVC

CEO, Xontogeny and Portfolio Manager, PXV Fund

perceptivelife.com/team/Boston, Massachusetts
Photo of Chris Garabedian, Investor at Perceptive Advisors

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Perceptive Advisors Investor
$100K - $10.0M
$1M
11
CompanyStageDateRound SizeTotal Raised
Nephraegis Therapeutics
Seed RoundMay 2021
Shifa Biomedical
Seed RoundMay 2021
Peroxitech Therapeutics
Seed RoundMay 2021
Tellus Therapeutics
Seed RoundMay 2021$2M
$2M
Juno Diagnostics
Series AMay 2021$25M
$25M
Forge Biologics
Series BApr 2021$120M
Series AJul 2020$40M
$160M
AsclepiX Therapeutics
Series AJun 2020$35M
$40M
Co-investors: Kevin Slawin (Rapha Capital Management)
CereVasc
Series AJun 2020$44M
$44M